Impact of Body Temperature Before and After Endovascular Thrombectomy for Large Vessel Occlusion Stroke
- 1 April 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 51 (4) , 1218-1225
Abstract
Background and Purpose—: In ischemic stroke, body temperature is associated with functional outcome. However, the relationship between temperature and outcome may differ in the intraischemic and postischemic phases of stroke. We aimed to determine whether body temperature before or after endovascular thrombectomy (EVT) for large vessel occlusion stroke is associated with clinical outcomes. Methods—: Consecutive EVT patients were identified from a prospective registry. Temperature measurements within 24 hours of admission were stratified into pre-EVT (preprocedural and intraprocedural) and post-EVT measurements, which served as surrogates for the intraischemic and postischemic phases of large vessel occlusion stroke, respectively. The primary outcome was functional independence, defined as a modified Rankin Scale score of 0, 1, or 2 at 3 months. Secondary outcomes included the ordinal shift of modified Rankin Scale scores at 3 months, symptomatic intracerebral hemorrhage, and mortality at 3 months. Results—: Four hundred thirty-two participants were included (59% men, mean±SD age 65.6±15.7 years). Multivariable logistic regression demonstrated that higher median pre-EVT temperature (per 1°C increase) was an independent predictor of reduced functional independence (odds ratio [OR], 0.66 [95% CI, 0.46–0.94]; P =0.02), poorer modified Rankin Scale scores (common OR, 1.42 [95% CI, 1.08–1.85]; P =0.01), and increased mortality (OR, 1.65 [95% CI, 1.02–2.69]; P =0.04). Peak post-EVT temperature (per 1°C increase) was a significant predictor of elevated modified Rankin Scale scores (common OR, 1.39 [95% CI, 1.03–1.90]; P =0.03) and higher mortality (OR, 1.66 [95% CI, 1.04–2.67]; P =0.03). Conclusions—: In patients with large vessel occlusion stroke treated with EVT, higher body temperatures during both the intraischemic and postischemic phases were associated with poorer clinical outcomes. Future research investigating the maintenance of normothermia or therapeutic hypothermia in patients needing to be transferred from primary to EVT-capable stroke centers could be considered.Keywords
This publication has 32 references indexed in Scilit:
- Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trialThe Lancet, 2011
- Low Rates of Acute Recanalization With Intravenous Recombinant Tissue Plasminogen Activator in Ischemic StrokeStroke, 2010
- The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trialThe Lancet Neurology, 2009
- Impact of Fever on Outcome in Patients With Stroke and Neurologic InjuryStroke, 2008
- Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysisBrain, 2007
- Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational studyThe Lancet, 2007
- Therapeutic Hypothermia for Acute Ischemic StrokeStroke, 2004
- Rapid and selective cerebral hypothermia achieved using a cooling helmetJournal of Neurosurgery, 2004
- Admission Body Temperature Predicts Long-Term Mortality After Acute StrokeStroke, 2002
- Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapyThe Lancet, 2000